Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

587
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
587
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

653
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
653

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV broadly neutralizing antibodies with enhanced Fc-CD16 affinity increase NK cell ADCC even with limited envelope binding.

bioRxiv : the preprint server for biology·2026
Same author

Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack.

bioRxiv : the preprint server for biology·2026
Same author

γc-cytokines in HIV Cure Research.

Current opinion in HIV and AIDS·2026
Same author

Retinoids enhance NK effector function against HIV-infected CD4 T cells.

Journal of virology·2026
Same author

RNA Polymerase III Regulates HIV Replication and Latency.

Viruses·2025
Same author

Glucose-Fueled Histone Modifications Drive HIV-1 Latency Reversal at Hypoxia.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 2, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.2K

HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Indra Sarabia1, Alberto Bosque1

  • 1Department of Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC 20052, USA.

Viruses
|December 5, 2019
PubMed
Summary

HIV-1 cure strategies are limited by latent virus reservoirs. This review explores how HIV-1 subtypes influence viral latency and reversal, crucial for developing global therapeutic approaches.

Keywords:
HIV-1HIV-1 latencycladeshock and killsubtype

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.0K

Related Experiment Videos

Last Updated: Jan 2, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.2K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.2K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.0K

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Latent HIV-1 infection is a major barrier to a cure, as current antiretroviral therapies do not eliminate these reservoirs.
  • HIV-1 exhibits significant genetic diversity, with over 10 subtypes and recombinant forms globally.
  • Current research on HIV-1 latency and reversal predominantly relies on subtype B, potentially limiting the efficacy of global cure strategies.

Purpose of the Study:

  • To review the existing literature on subtype-specific factors influencing HIV-1 replication, pathogenesis, latency, and latency reversal.
  • To highlight the need for a comprehensive understanding of how viral diversity impacts HIV-1 latency.
  • To inform the development of universally applicable therapeutic strategies for HIV-1 cure.

Main Methods:

  • Literature review of scientific articles on HIV-1 subtypes, latency, and reversal.
  • Analysis of studies investigating the impact of genetic diversity on viral characteristics.
  • Synthesis of current knowledge on subtype-specific latency mechanisms.

Main Results:

  • The influence of HIV-1 subtype on latency establishment and reactivation remains incompletely understood.
  • Most research focuses on subtype B, potentially overlooking crucial differences in other subtypes.
  • Subtype-specific variations may affect viral replication, pathogenesis, and the ability to reverse latency.

Conclusions:

  • Understanding subtype-specific factors is essential for developing effective, worldwide HIV-1 cure strategies.
  • Further research is needed to elucidate the role of genetic diversity in HIV-1 latency.
  • Addressing viral diversity will improve the development of therapies targeting latent HIV-1 reservoirs.